Giving Kids Sedatives May Classify as Abuse

Article

Findings from a new study suggest that giving children drugs for malicious reasons should be classified as abuse, and is an under-recognized national problem.

Parents who give their kids medications that they might not need to help them sleep during a plane ride may want to think twice before doing it again.

Findings from a new study suggest that giving children drugs for malicious reasons should be classified as abuse, and is an under-recognized national problem.

In the study, which is set to be published in the Journal of Pediatrics, Shan Yin, MD, of the University of Colorado and the Rocky Mountain Poison Drug Center at Denver Health, and colleagues found that abuse results in more than 150 cases and two deaths every year.

Using the National Poison Data System, the researchers found and reviewed more than 1,400 reports of malicious use of drugs on children, including use of alcohol, antipsychotics, painkillers, cough and cold medicines, sedatives, and sleeping pills.

Their findings were as follows: nearly 14% of cases resulted in moderate to major consequences, including death of the child; nearly 50% of children were given at least one sedative; and an average of 160 cases, including two deaths, were reported each year.

In the report, Yin noted that there are various known motives for abusing children with drugs, ranging from punishment and amusement, to a desire to have a break from childcare. He urges pediatricians and emergency medical personnel “to be on the watch for this form of maltreatment, and suggests the use of comprehensive drug screening during the evaluation of a child suspected to be the victim of abuse.”

Related Videos
Insight on the Promising 52-Week KarXT Data with Rishi Kakar, MD
Sunny Rai, PhD: “I” Language Markers Do Not Detect Depression in Black Individuals
Rebecca A. Andrews, MD: Issues and Steps to Improve MDD Performance Measures
A Voice Detecting Depression? Lindsey Venesky, PhD, Discusses New Data
Daniel Karlin, MD: FDA Grants Breakthrough Designation to MM120 for Anxiety
Leesha Ellis-Cox: Steps to Closing the Bipolar Disorder Diagnosis Gap for Blacks
Daniel Greer, PharmD: Reduction in Rehospitalizations with Antipsychotic Injections for Schizophrenia
© 2024 MJH Life Sciences

All rights reserved.